During states of infection and inflammation, systemic interleukin 1 (IL-1) results in clear biological effects mediated through the central nervous system, such as fever, anorexia, and activation of the hypothalamic-pituitary-adreno-cortical axis. Given the multiple central effects of IL-1 in the rat, it would be expected that IL-1 receptors ought to be present in rat brain. However, no previous studies have localized IL-1 receptor or its mRNA in rat brain, possibly due to the fact that interspecies probes were used in previous studies. The recent cloning of the rat IL-1 type-I receptor (IL-1RI) has permitted us to conduct an in situ hybridization study using a species-specific,35S-labeled anti-sense riboprobe to localize IL-1 receptor mRNA in rat brain. We localized IL1-1RI mRNA in the hippocampus, choroid plexus, and cerebellum. At the cellular level we found H-IRI mRNA in low to moderate levels in hippocam-pal neurons and in Purkinje cells of the cerebellar cortex, and in high levels in the endothelium of postcapillary venules and in glial cells surrounding arterioles throughout the brain. This pattern of localization provides support to the concept that IL-1 crosses the blood-brain barrier. Future studies are needed to clarify how the expression of the gene encoding IL-1RI is regulated in brain tissue.

Keywords:
Receptors, Interleukin 1, Rattus norvegicus, mRNA, Nucleic acid hybridization, Probes, Brain, Cerebellum, Hippocampus, Blood-brain barrier
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.